Glaxosmithkline (GSK)

Company name:Glaxosmithkline Plc
Company Description:A group engaged in the creation; discovery; development; manufacture and marketing of pharmaceutical and consumer health-related products
COD:GSKTrading Currency:GBX
Market Sector:FE10ISIN:GB0009252882
Market Segment:SET1Share Type:DE
WWW Address:http://www.gsk.com/Description:ORD 25P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Variação [%] Bid Offer Abertura MAX MIN Volume
 1,594.20 br.advfn.com/p.php?gfx=/br/down -1.0 [-0.06] 1,594.00 1,594.40 1,607.40 1,608.00 1,587.20 1,321,802
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52 Semanas
 79,143.45 4,964.46 0.15 73.70 80.00 21.63 5.02 1,648.80 - 1,408.80

Glaxosmithkline Key Figures

Key Figures
(at previous day's close)
Market Cap.79,143.45m
Shares In Issue4,964.46m
Prev. Close1,595.20
PE Ratio21.63 
Dividend Yield5.02%
EPS - basic73.70p
Dividend PS80.00p
Dividend Cover0.92 
Cash Flow PS169.63p
Return On Equity (ROE)83.10%
Operating Margin13.13%
PEG Factor0.16 
EPS Growth Rate134.71%
Dividends PS Growth Rate-%
Dívida Líquida50,520.00m
Gross Gearing93.68%
Quick Assets15,066.00m
Net Working Capital-1,949.00m
Intangibles / Fixed Assets61.27%
Turnover PS620.83p
Pre-Tax Profit PS81.54p
Retained Profit PS-6.12p
Cash PS78.03p
Net Cash PS-375.01p
Net Tangible Asset Value PS *-375.29p
Net Asset Value PS73.97p
Spread0.40 (0.03%) 

Glaxosmithkline Balance Sheet

%1$s Balance Sheet
LSE:GSK:Liabilities+EQLSE:GSK:Assets

Share Price Performance

Share Price Performance
Sample Period MAXMIN
1 Semana1,616.001,561.20
4 Semanas1,616.001,510.40
12 Semanas1,616.001,495.40
1 Ano1,648.801,408.80

Share Price Chart (5 years)

Share Price Chart (5 years)

Glaxosmithkline Historic Returns

%1$s Historic Returns
Período AberturaVAB%Abertura MédiaVol Diário Médio [m]Volume [m]VWAP
1 Semana1,563.4030.801.971,561.206.671,587.43
4 Semanas1,547.0047.203.051,510.408.161,560.44
12 Semanas1,564.4029.801.901,495.408.071,558.80
26 Semanas1,518.0076.205.021,429.808.231,534.18
1 Ano1,544.0050.203.251,408.808.791,532.80
3 Anos1,405.50188.7013.431,236.409.141,522.23
5 Anos1,585.009.200.581,227.509.081,483.06

Glaxosmithkline Key Management Ratios

DEEPER ANALYSIS

Glaxosmithkline Investment Ratios

%1$s Investment Ratios
(Market value analysis) at previous day's close
PQ Ratio26.90 
PE Ratio21.63 
Tobin's Q Ratio 1.38 
Tobin's Q Ratio (excl. intangibles)2.32 
Dividend Yield5.02%
Market-to-Book Ratio18.15 
Price-to-Pre-Tax Profit PS19.55 
Price-to-Retained Profit PS-260.34 
Price-to-Cash Flow PS9.40 
Price-to-Sales PS2.57 
Price-to-Net Tangible Asset Value PS-4.10 
Price-to-Cash PS20.43 
Net Working Capital PS-39.26 
Price Pct to Working Capital PS-40.61%
Earnings Yield4.62%
Average PE35.41 
Years in average5 
PE to PE average61.09%

Glaxosmithkline Financial Ratios

%1$s Financial Ratios
(Leverage Ratios)
Debt Ratio89.68%
Debt-to-Equity Ratio8.69 
Debt-to-Equity Ratio (excl. Intgbl)-1.65 
Debt-to-Equity Market Value0.40 
Net Gearing87.00%
Net Gearing (excl. Intangibles)144.03%
Gross Gearing93.68%
Gross Gearing (excl. Intangibles)155.08%
Gearing Under 1 Year38.73%
Gearing Under 1 Year (excl. Intgbl)64.12%
Assets/Equity15.81 
Cash/Equity105.50 
(Liquidity Ratios)
Net Working Capital to Total Assets-3.36%
Current Ratio0.91 
Quick Ratio (Acid Test)0.67 
Liquidity Ratio0.17 
Cash & Equiv/Current Assets18.86%
(Solvency Ratios)
Enterprise Value106,484.45m
CFO/Sales0.27 
CFO/Attributable Profit2.32 
CFO/Assets0.15 
CFO/Debt0.15 
Total Debt/Equity Market Value0.69 
Total Debt/Sales1.76 
Total Debt/Pre-Tax Profit13.44 
Total Debt54,394.00m
Total Debt/Net Current Assets-27.91%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth57.68%
5 yr Compound Earnings Growth5.16%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs9 
Beta coefficients
Beta (60-Mnth)Beta (36-Mnth)
0.1502-0.1237

Glaxosmithkline Operating Ratios

%1$s Operating Ratios
(Profitability Ratios)
Return On Capital Employed (ROCE)11.38%
Return On Assets (ROA)6.33%
Net Profit Margin11.75%
Assets Turnover0.54 
Return On Equity (ROE)83.10%
Return On Investment (ROI)11.08%
Dividend Payout Ratio108.55%
Plowback Ratio-8.55%
Growth from Plowback Ratio-14.43%
Net Income Of Revenues-0.99%
(Asset Utilisation Multiples)
Shareholders Equity Turnover14.36 
Fixed Assets Turnover0.83 
Current Assets Turnover1.54 
Net Working Capital Turnover 
Inventory Turnover5.59 
(Other Operating Ratios)
Total Assets-to-Sales1.86 
Debtors-to-Sales33.41%
Debt Collection Period121.94Dias

Glaxosmithkline Dividends

%1$s Dividends
DataTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
06 Fev 2019FinalGBX23.0031/12/201731/12/201821/02/201922/02/201911/04/201980.00
31 Out 2018QuarterlyGBX19.0031/12/201731/12/201815/11/201816/11/201810/01/2019-
25 Jul 2018QuarterlyGBX19.0031/12/201731/12/201809/08/201810/08/201811/10/2018-
25 Abr 2018QuarterlyGBX19.0031/12/201731/12/201810/05/201811/05/201812/07/2018-
07 Fev 2018FinalGBX23.0031/12/201631/12/201722/02/201823/02/201812/04/201880.00
25 Out 2017QuarterlyGBX19.0031/12/201631/12/201709/11/201710/11/201711/01/2018-
26 Jul 2017QuarterlyGBX19.0031/12/201631/12/201710/08/201711/08/201712/10/2017-
26 Abr 2017QuarterlyGBX19.0031/12/201631/12/201711/05/201712/05/201713/07/2017-
08 Fev 2017FinalGBX23.0031/12/201531/12/201623/02/201724/02/201713/04/201780.00
26 Out 2016QuarterlyGBX19.0031/12/201531/12/201603/11/201604/11/201612/01/2017-
27 Jul 2016QuarterlyGBX19.0031/12/201531/12/201611/08/201612/08/201613/10/2016-
27 Abr 2016QuarterlyGBX19.0031/12/201531/12/201612/05/201613/05/201614/07/2016-
03 Fev 2016FinalGBX23.0031/12/201431/12/201518/02/201619/02/201614/04/2016100.00
03 Fev 2016SpecialGBX20.0031/12/201431/12/201518/02/201619/02/201614/04/2016-
19 Out 2015QuarterlyGBX19.0031/12/201431/12/201512/11/201513/11/201514/01/2016-
29 Jul 2015QuarterlyGBX19.0031/12/201431/12/201513/08/201514/08/201501/10/2015-
06 Mai 2015QuarterlyGBX19.0031/12/201431/12/201514/05/201515/05/201509/07/2015-
04 Fev 2015FinalGBX23.0031/12/201331/12/201419/02/201520/02/201509/04/201580.00
22 Out 2014QuarterlyGBX19.0031/12/201331/12/201406/11/201407/11/201408/01/2015-
24 Jul 2014QuarterlyGBX19.0031/12/201331/12/201406/08/201408/08/201402/10/2014-
30 Abr 2014QuarterlyGBX19.0031/12/201331/12/201414/05/201416/05/201410/07/2014-
05 Fev 2014FinalGBX23.0031/12/201231/12/201319/02/201421/02/201410/04/201478.00
23 Out 2013QuarterlyGBX19.0031/12/201231/12/201313/11/201315/11/201309/01/2014-
24 Jul 2013QuarterlyGBX18.0031/12/201231/12/201307/08/201309/08/201303/10/2013-
24 Abr 2013QuarterlyGBX18.0031/12/201231/12/201308/05/201310/05/201311/07/2013-
06 Fev 2013FinalGBX22.0031/12/201131/12/201220/02/201322/02/201311/04/201374.00
31 Out 2012QuarterlyGBX18.0031/12/201131/12/201214/11/201216/11/201203/01/2013-
25 Jul 2012QuarterlyGBX17.0031/12/201131/12/201208/08/201210/08/201204/10/2012-
25 Abr 2012QuarterlyGBX17.0031/12/201131/12/201209/05/201211/05/201205/07/2012-
07 Fev 2012SpecialGBX5.0031/12/201031/12/201115/02/201217/02/201212/04/2012-
07 Fev 2012FinalGBX21.0031/12/201031/12/201115/02/201217/02/201212/04/201275.00
26 Out 2011InterimGBX17.0031/12/201031/12/201102/11/201104/11/201105/01/2012-
26 Jul 2011InterimGBX16.0031/12/201031/12/201103/08/201105/08/201106/10/2011-
27 Abr 2011InterimGBX16.0031/12/201031/12/201104/05/201106/05/201107/07/2011-
03 Fev 2011FinalGBX19.0031/12/200931/12/201009/02/201111/02/201107/04/201165.00
21 Out 2010InterimGBX16.0031/12/200931/12/201027/10/201029/10/201006/01/2011-
21 Jul 2010InterimGBX15.0031/12/200931/12/201028/07/201030/07/201007/10/2010-
28 Abr 2010InterimGBX15.0031/12/200931/12/201005/05/201007/05/201008/07/2010-
04 Fev 2010FinalGBX18.0031/12/200831/12/200910/02/201012/02/201008/04/201061.00
29 Out 2009QuarterlyGBX15.0031/12/200831/12/200904/11/200906/09/200907/01/2010-
30 Jul 2009QuarterlyGBX14.0031/12/200831/12/200931/07/200931/07/200908/10/200928.00
22 Abr 2009QuarterlyGBX14.0031/12/200831/12/200929/04/200901/05/200909/07/2009-
05 Fev 2009FinalGBX17.0031/12/200731/12/200811/02/200913/02/200909/04/200957.00
22 Out 2008QuarterlyGBX14.0031/12/200731/12/200829/10/200831/10/200809/01/2008-
07 Fev 2008FinalGBX13.0031/12/200631/12/200713/02/200815/02/200810/04/200853.00
25 Jul 2007QuarterlyGBX12.0031/12/200631/12/200701/08/200703/08/200711/10/2007-
24 Abr 2007QuarterlyGBX12.0031/12/200631/12/200702/05/200704/05/200712/07/2007-
08 Fev 2007QuarterlyGBX14.0031/12/200531/12/200614/02/200616/02/200612/04/2007-
08 Fev 2007FinalGBX-31/12/200531/12/2006---48.00
26 Out 2006QuarterlyGBX12.0031/12/200531/12/200601/11/200603/11/200604/01/2007-
26 Jul 2006QuarterlyGBX11.0031/12/200531/12/200602/08/200604/08/200605/10/2006-
27 Abr 2006QuarterlyGBX11.0031/12/200531/12/200610/05/200612/05/200606/07/2006-
08 Fev 2006FinalGBX14.0031/12/200431/12/200515/02/200617/02/200606/04/200644.00
27 Out 2005QuarterlyGBX10.0031/12/200431/12/200502/11/200504/11/200505/01/2006-
29 Jul 2005QuarterlyGBX10.0031/12/200431/12/200503/08/200505/08/200506/10/2005-
28 Abr 2005QuarterlyGBX10.0031/12/200431/12/200511/05/200513/05/200507/07/2005-
10 Fev 2005FinalGBX12.0031/12/200331/12/200416/02/200518/02/200507/04/200542.00
28 Out 2004QuarterlyGBX10.0031/12/200331/12/200403/11/200405/11/200406/01/2005-
27 Jul 2004QuarterlyGBX10.0031/12/200331/12/200404/08/200406/08/200430/09/2004-
27 Jul 2004QuarterlyGBX10.0031/12/200331/12/200412/05/200414/05/200401/07/2004-
12 Fev 2004FinalGBX14.0031/12/200231/12/200318/02/200420/02/200415/04/200441.00
11 Fev 2004QuarterlyGBX9.0031/12/200231/12/200329/10/200331/10/200306/01/2004-
23 Jul 2003QuarterlyGBX9.0031/12/200231/12/200330/07/200301/08/200302/10/2003-
30 Abr 2003QuarterlyGBX9.0031/12/200231/12/200307/05/200309/05/200303/07/2003-
12 Fev 2003FinalGBX13.0031/12/200131/12/200219/02/200321/02/200317/04/200340.00
23 Out 2002QuarterlyGBX9.0030/03/200230/09/200230/10/200201/11/200203/01/2003-
24 Jul 2002QuarterlyGBX9.0030/12/200130/06/200231/07/200202/08/200203/10/2002-
25 Abr 2002QuarterlyGBX9.0001/10/200131/03/200201/05/200203/05/200204/07/2002-
14 Fev 2002FinalGBX12.0031/12/200031/12/200120/02/200222/02/200218/04/200239.00
23 Out 2001QuarterlyGBX9.0030/09/200030/09/200131/10/200102/11/200103/01/2002-
24 Jul 2001QuarterlyGBX9.0030/06/200030/06/200101/08/200103/08/200104/10/2001-
24 Abr 2001QuarterlyGBX9.0031/03/200031/03/200102/05/200104/05/200105/07/2001-
13 Dez 2000FinalGBX23.0031/12/199931/12/200018/12/200022/12/200017/04/200138.00
27 Jul 2000InterimGBX15.0030/12/199930/06/200007/08/200011/08/200016/10/2000-
16 Fev 2000FinalGBX22.0031/12/199831/12/199928/02/200003/03/200025/05/200037.00
29 Jul 1999InterimGBX15.0030/12/199830/06/199909/08/199913/08/199901/10/1999-
18 Fev 1999FinalGBX21.0031/12/199731/12/199801/03/199905/03/199920/05/199936.00

Glaxosmithkline Fundamentals

Profit and Loss Account
 31 Dez 2015 (GBP)31 Dez 2016 (GBP)31 Dez 2017 (GBP)31 Dez 2018 (GBP)
turnover23,923.00100.00%27,889.00100.00%30,186.00100.00%30,821.00100.00%m
pre tax profit10,526.0044.00%1,939.006.95%3,525.0011.68%4,048.0013.13%m
attributable profit8,422.0035.20%912.003.27%1,532.005.08%3,623.0011.75%m
retained profit4,548.0019.01%-3,938.00-14.12%-2,374.00-7.86%-304.00-0.99%m
eps - basic (p)174.30 18.80 31.40 73.70 
eps - diluted (p)172.30 18.60 31.00 72.90 
dividends per share100.00 80.00 80.00 80.00 

Glaxosmithkline Balance Sheet

Balance Sheet
 31 Dez 2015 (GBP)31 Dez 2016 (GBP)31 Dez 2017 (GBP)31 Dez 2018 (GBP)
LSE:GSK:Liabilities+EQLSE:GSK:AssetsLSE:GSK:Liabilities+EQLSE:GSK:AssetsLSE:GSK:Liabilities+EQLSE:GSK:AssetsLSE:GSK:Liabilities+EQLSE:GSK:Assets
 31 Dez 2015 (GBP)31 Dez 2016 (GBP)31 Dez 2017 (GBP)31 Dez 2018 (GBP)
ASSETS
fixed assets fixed assets9,668.0018.09%10,808.0018.29%10,860.0019.26%11,058.0019.04%m
intangibles intangibles21,834.0040.85%24,741.0041.88%23,296.0041.32%22,991.0039.59%m
fixed investments fixed investments2,652.004.96%2,692.004.56%2,668.004.73%3,475.005.98%m
current assets - other current assets - other46.000.09%215.000.36%113.000.20%653.001.12%m
stocks stocks4,716.008.82%5,102.008.64%5,557.009.86%5,476.009.43%m
debtors debtors8,700.0016.28%10,626.0017.99%10,054.0017.83%10,539.0018.15%m
cash & securities cash & securities5,830.0010.91%4,897.008.29%3,833.006.80%3,874.006.67%m
TOTAL53,446.00100%59,081.00100%56,381.00100%58,066.00100%m
LIABILITIES
creditors - short creditors - short13,417.0025.10%19,001.0032.16%26,569.0047.12%22,491.0038.73%m
creditors - long creditors - long31,151.0058.28%35,117.0059.44%26,323.0046.69%31,903.0054.94%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL44,568.0083.39%54,118.0091.60%52,892.0093.81%54,394.0093.68%m
EQUITY
ord cap, reserves ord cap, reserves5,114.009.57%1,124.001.90%-68.00-0.12%4,360.007.51%m
prefs, minorities prefs, minorities3,764.007.04%3,839.006.50%3,557.006.31%-688.00-1.18%m
TOTAL8,878.0016.61%4,963.008.40%3,489.006.19%3,672.006.32%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Glaxosmithkline Cash Flow Statement

%1$s Cash Flow Statement
31 Dez 2015 (GBP)31 Dez 2016 (GBP)31 Dez 2017 (GBP)31 Dez 2018 (GBP)
Operating CF2,569.006,497.006,918.008,421.00m
Pre-Financing CF8,606.005,228.005,475.006,868.00m
Retained CF1,503.00-1,164.00-905.00479.00m

Glaxosmithkline Brokers

%1$s Brokers
NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Seu Histórico Recente
LSE
GSK
Glaxosmith..
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4191 5205.
P: V:br D:20190619 09:21:11